1. Home
  2. TRDA vs NCMI Comparison

TRDA vs NCMI Comparison

Compare TRDA & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$7.37

Market Cap

274.5M

Sector

Health Care

ML Signal

HOLD

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

HOLD

Current Price

$3.79

Market Cap

306.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
NCMI
Founded
2016
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
274.5M
306.0M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
TRDA
NCMI
Price
$7.37
$3.79
Analyst Decision
Strong Buy
Buy
Analyst Count
3
4
Target Price
$21.00
$5.63
AVG Volume (30 Days)
279.1K
489.0K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
3.36%
EPS Growth
N/A
52.17
EPS
N/A
N/A
Revenue
$25,421,000.00
N/A
Revenue This Year
$39.97
$11.20
Revenue Next Year
$50.80
$6.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$2.80
52 Week High
$16.45
$5.14

Technical Indicators

Market Signals
Indicator
TRDA
NCMI
Relative Strength Index (RSI) 50.31 64.71
Support Level $5.75 $3.77
Resistance Level $10.82 $4.02
Average True Range (ATR) 0.52 0.14
MACD 0.26 0.02
Stochastic Oscillator 77.36 81.65

Price Performance

Historical Comparison
TRDA
NCMI

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: